In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

A single blood test that looks for signs of dozens of cancers sounds revolutionary—but it's important to understand both its ...

If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...

SimpleScreen CRC is indicated for adults 45 and up at average risk ...

Some claim the new multi-cancer detection tests will “revolutionize” cancer screening. Others fear the “worried well” will succumb to slick marketing and subpar tests and overwhelm both primary care ...

Since its peak in 1991, the cancer death rate has dropped 34%, averting an estimated 4.5 million deaths due, in part, to earlier detection of the most common types of cancer. Screening tests are ...

Cervical cancer screenings are considered one of the most significant public health advances of the past 50 years, particularly in detecting HPV (human papillomavirus), the culprit of most cervical ...

July 27 (Reuters) - The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott to launch it in the U.S. this fall, the ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...